Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orum Therapeutics
Biotech
Vertex mines for more gene editing riches with $15M Orum deal
Vertex is looking to extend its claim in gene editing through a small licensing deal with South Korea's Orum.
Darren Incorvaia
Jul 16, 2024 7:00am
BMS snags another ADC with modest $100M Orum deal
Nov 6, 2023 7:00am
Orum adds $54M to 2019 series B to move ADCs into the clinic
Jun 23, 2021 9:41am
Orum bags $30M to build out its platform to drug the 'undruggable'
Jul 17, 2019 12:00am
Korean biotech Orum raises $8M for cell-penetrating antibody tech
Jun 14, 2017 8:00am
Cracking an 'undruggable' cancer mutation
May 11, 2017 12:44pm
